R Squared Ltd Acquires New Shares in Utah Medical Products, Inc. $UTMD

R Squared Ltd acquired a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,679 shares of the medical instruments supplier’s stock, valued at approximately $209,000. R Squared Ltd owned approximately 0.11% of Utah Medical Products at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of Utah Medical Products by 35.2% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 101,640 shares of the medical instruments supplier’s stock valued at $5,696,000 after acquiring an additional 26,460 shares in the last quarter. Minerva Advisors LLC raised its holdings in shares of Utah Medical Products by 10.9% in the first quarter. Minerva Advisors LLC now owns 86,902 shares of the medical instruments supplier’s stock valued at $4,870,000 after acquiring an additional 8,513 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of Utah Medical Products by 2.7% in the first quarter. Bank of New York Mellon Corp now owns 48,612 shares of the medical instruments supplier’s stock valued at $2,724,000 after acquiring an additional 1,277 shares in the last quarter. Huber Capital Management LLC raised its holdings in shares of Utah Medical Products by 38.9% in the first quarter. Huber Capital Management LLC now owns 39,819 shares of the medical instruments supplier’s stock valued at $2,231,000 after acquiring an additional 11,149 shares in the last quarter. Finally, Isthmus Partners LLC raised its holdings in shares of Utah Medical Products by 4.6% in the first quarter. Isthmus Partners LLC now owns 32,923 shares of the medical instruments supplier’s stock valued at $1,845,000 after acquiring an additional 1,459 shares in the last quarter. 69.60% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Utah Medical Products in a report on Friday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Utah Medical Products Stock Down 0.0%

Shares of Utah Medical Products stock opened at $60.43 on Friday. The firm’s 50 day moving average price is $61.64 and its 200-day moving average price is $57.44. Utah Medical Products, Inc. has a 52-week low of $51.26 and a 52-week high of $68.99. The company has a market cap of $193.98 million, a P/E ratio of 17.07 and a beta of 0.32.

Utah Medical Products (NASDAQ:UTMD) last issued its quarterly earnings data on Thursday, October 23rd. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 30.08% and a return on equity of 9.90%. The firm had revenue of $9.81 million for the quarter.

Utah Medical Products Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 2nd. Stockholders of record on Wednesday, September 17th were given a $0.305 dividend. The ex-dividend date of this dividend was Wednesday, September 17th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.0%. Utah Medical Products’s payout ratio is presently 34.46%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.